type of [100:55 mg 2 /dL 2 : Decrease or suspend dose and/or adjust dose of phosphate binders; if dose is suspended, resume at a reduced dose; decrease each dose (not weekly dose) by at least 2.5 mcg. Predialysis patients: Initial dose: iPTH >70 pg/mL with stage 3 disease or >110 pg/mL with stage 4 disease: 1 mcg/day for 2 weeks Dose titration: iPTH level >70 pg/mL with stage 3 disease or >110 pg/mL with stage 4 disease (dose should be titrated to lower iPTH to 35 to 70 pg/mL with stage 3 disease or to 70 to 110 pg/mL with stage 4 disease): Increase dose by 0.5 mcg per day every 2 weeks as necessary (maximum dose: 3.5 mcg/day) iPTH level 35 to 70 pg/mL with stage 3 disease or 70 to 110 pg/mL with stage 4 disease: Maintain current dose iPTH level is] Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Doxercalciferol Rating No Reviews - Be the first! 8.0 /10 No Reviews - Be the first! 8.0 Rate it! Manufacturers Roxane Laboratories, Inc. Sandoz Inc. Prasco Laboratories Hikma Pharmaceuticals PLC More... Drug Class Vitamins Related Drugs vitamins cholecalciferol , cyanocobalamin , folic acid , ergocalciferol , Vitamin D3 , biotin Secondary Hyperparathyroidism Sensipar , Zemplar , cinacalcet , paricalcitol , Hectorol , More... Doxercalciferol Images Doxercalciferol systemic 0.5 mcg (r ) View all images beat back
yet another Doxercalciferol that i wonder
EmoticonEmoticon